Autophagy regulatory machinery

The autophagy regulatory machinery is a highly coordinated system of proteins, including the ATG family, ULK1 complex, and VPS34 complex, that governs the process of macroautophagy (Mizushima & Komatsu, 2011, Cell). This machinery is essential for cellular quality control, facilitating the sequestration of damaged organelles and protein aggregates into double-membrane autophagosomes for lysosomal degradation (Levine & Kroemer, 2019, Cell). In health, it maintains metabolic balance and protects against infection; however, its dysfunction is a hallmark of neurodegenerative diseases like Alzheimer's and Parkinson's, where protein clearance is compromised (Djajadikerta et al., 2020, Frontiers in Cell and Developmental Biology). In oncology, the machinery exhibits a dual role, acting as a tumor suppressor during initiation but supporting the survival of established tumors under metabolic stress (White et al., 2015, Genes & Development). Therapeutic strategies include the use of mTOR inhibitors such as rapamycin to stimulate autophagy or lysosomotropic agents like hydroxychloroquine to block the final stages of the pathway (Klionsky et al., 2021, Autophagy). Emerging drug candidates specifically target individual components like ULK1 or VPS34 to achieve more precise control over the pathway in various disease contexts (Galluzzi et al., 2017, EMBO Journal).

Other names

Autophagy pathwayMacroautophagy machineryATG protein systemAutophagic machinery

Pharmacological modulation of the autophagy regulatory machinery involves either the induction of the pathway via mTORC1 inhibition or AMPK activation, or the inhibition of the pathway through the disruption of autophagosome-lysosome fusion or the inhibition of key initiation kinases like ULK1 and VPS34 (Galluzzi et al., 2017, EMBO Journal).